Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Panconesi E, Hautmann G. Psychophysiology of stress in dermatology. Dermatol. Clin. 1996; 14(3): 399–420.
Koblenzer CS. Psychosomatic concepts in dermatology. Arch. Dermatol. 1983; 119: 501–12.
Fitzpatrick TB, Johnson RA, Wolff K. Color Atlas and Synopsis of Clinical Dermatology. New York: McGraw-Hill, 2001, pp. 50–60.
Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen. Hosp. Psychiatry 1987; 9: 157–66.
Arnetz BB, et al. Stress and psoriasis. Psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom. Med. 1985; 47: 528–41.
Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol. Clin. 1996: 14(3): 485–96.
Gupta MA, Gupta AK, Kirkby S, et al. Pruritis in psoriasis: a prospective study of some psychiatric and dermatologic correlates. Arch. Dermatol. 1988; 124: 1052–7.
Gupta MA, Gupta AK, Kirkby S, et al. A psychocutaneous profile of psoriasis patients who are stress reactors: a study of 17 patients. Gen. Hosp. Psychiatry 1989; 11: 166–73.
Ginsburg IH. Coping with psoriasis: a guide for counseling patients. Cutis 1996; 57: 323–30.
Ginsburg IH. Psychological and psychophysiological aspects of psoriasis. Dermatol. Clin. 1995; 13: 793–99.
Tausk F, Whitmore SE. A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother. Psychosom. 1991; 68: 221–9.
Gupta MA, et al. Depression modulates pruritis perception: a study of pruritis in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom. Med. 1994; 56: 36–40.
Ullman KC, Moore RW, Redi M. Atopic eczema: a clinical psychiatric study. J. Asthma Res. 1977; 14: 91–9.
Kirshbaum BA. Eczema and Emotions. Kalamazoo, MI:n Upjohn Company, 1982, pp. 35–55.
Jordan JM, Whitlock FA. Emotions and the skin: the conditioning of scratch responses in cases of atopic dermatitis. Br. J. Dermatol. 1972; 86: 574–85.
Gupta MA, Gupta AK, Ellis CN. Antidepressant drugs in dermatology. Arch. Dermatol. 1987; 123: 647–52.
Muller SA, Winkelman RK. Alopecia areata: an evaluation of 736 patients. Arch. Dermatol. 1963; 88: 290–7.
Koo JY, et al. Alopecia areata and increased prevalence of psychiatric disorders. Int. J. Dermatol. 1994; 33: 849–50.
MacAlpine I. Is alopecia areata psychosomatic? A psychiatric study. Br. J. Dermatol. 1958; 70: 117–31.
Perini G, et al. Imipramine in alopecia areata: a double blind, placebo-controlled study. Psychother. Psychosom. 1994; 61: 195–8.
Warin RP, Champion RH. Urticaria. Philadelphia: WB Saunders, 1974.
Gupta MA, Gupta AK. Psychodermatology: an update. J. Am. Acad. Dermatol. 1996; 124(6): 1030–46.
Greene SL, Reed CE, Schroeter AL. Double blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J. Am. Acad. Dermatol. 1985; 12: 669–75.
Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch. Dermatol. 1987; 123: 913–6.
Garcia-Pola Vallejo MJ, Huerta G, Cerero R. Anxiety and depression as risk factors for oral lichen planus. Dermatology 2001; 203: 303–7.
Burkhart NW, et al. Assessing the characteristics of patients with oral lichen planus. J. Am. Acad. Dermatol. 1996; 127: 648–60.
Conklin RJ, Blasberg B. Oral lichen planus. Dermatol. Clin. 1987; 5(4): 663–72.
Zanol K, Slaughter J, Hall R. An approach to the treatment of psychogenic parasitosis. Int. J. Dermatol. 1998; 37: 56–63.
Koo J, Gambla C. Psychopharmacology for dermatologic patients. Dermatol. Clin. 1996; 14(3): 500–22.
Fabisch W. Psychiatric aspects of dermatitis artefacta. Br. J. Dermatol. l980; 102: 29–34.
Niemeier V, et al. Coping with acne vulgaris. Dermatology 1996: 196: 108–15.
Fabisch W. What is dermatitis artefacta? Int. J. Dermatol. 1981; 20: 427–8.
Freunsgaard K. Neurotic excoriations: a controlled psychiatric examination. Acta Psychiatr. Scand. 1984; 69(S): 1–52.
Seitz PFD. Psychocutaneous aspects of persistent pruritis and excessive excoriation. Arch. Dermatol. Syphiligr. 1951; 64: 136–41.
Obermayer ME. Psychocutaneous medicine. Springfield, IL: Charles C. Thomas, 1955.
Oguchi T, Miura S. Trichotillomania: its psychopathological aspect. Compr. Psychiatry 1977; 18: 177–82.
Greenberg R, Sarner CA. Trichotillomania: symptom and syndrome. Arch. Gen. Psychiatry 1965; 12: 482–9.
Odom RB, James WD, Berger TG. Psychodermatology. Andrews Diseases of the Skin. Philadelphia: WB Saunders, 2000, pp. 59–63.
Koblenzer CS. Cutaneous manifestations of psychiatric disease that commonly present to the dermatologist. Int. J. Psychiatry Med. 1992; 22(1): 47–63.
Gupta MA, Gupta AK, Haberman HF. The self-inflicted dermatoses: a critical review. Gen. Hosp. Psychiatry 1987; 9: 45–52.
Cotterill JA. Body dysmorphic disorder. Dermatol. Clin. 1996; 14(3): 457–7.
Trikkas G, et al. Glossodynia. Personality characteristics and psychopathology. Psychother. Psychosom. 1996; 65: 158–62.
Koo J, Gambla C. Cutaneous sensory disorder. Dermatol. Clin. 1996; 14(3): 497–502.
Hoss D, Segal S. Scalp dysesthesia. Arch. Dermatol. 1998; 134: 327–30.
Ginsburg IH. The psychosocial impact of skin disease. Dermatol. Clin. 1996; 14(3): 473–84.
Koo J. The psychosocial impact of acne: patients’ perceptions. J. Am. Acad. Dermatol. 1995; 32: S26–30.
Hull SM, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphobic acne patient. Clin. Exp. Dermatol. 1991; 16: 210–1.
Grimes PE. White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J. Am. Acad. Dermatol. 2004; 51(1): S5–6.
Mason PJ. Vitiligo. The psychosocial effects. Medsurg. Nurs. 1997; 6: 216–22.
Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioral therapy. Br. J. Med. Psychol. 1999; 72: 385–96.
Rook A, Wilkinson DS. Psychocutaneous disorders. Textbook of Dermatology. Oxford: Blackwell, 1979, pp. 2023–35.
Medansky RS, Handler RM. Dermatopsychosomatics. Classification, physiology, and therapeutic approaches. J. Am. Acad. Dermatol. 1981; 5: 125–36.
Gupta MA, Voorhees JJ. Psychosomatic dermatology: is it relevant? Arch. Dermatol. 1990; 126: 90–3.
Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc. Sci. Med. 1985; 20: 425–9.
Ostlere LS, Hardy D, Denton C, et al. Boxing glove hand: an unusual presentation of dermatitis artefacta. J. Am. Acad. Dermatol. 1993; 28: 120–2.
Perry HO, Brunsting LA. Pemphigus foliaceus. Arch. Dermatol. 1965; 91: 10–23.
Gupta MA, Gupta AK, Haberman HF. Dermatologic signs in anorexia nervosa and bulimia nervosa. Arch. Dermatol. 1987; 123: 1386–90.
Koblenzer CS, Bostrom P. Chronic cutaneous dysesthesia syndrome: a psychotic phenomenon or a depressive symptom? J. Am. Acad. Dermatol. 1994; 30: 370–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Liverant, E. (2008). Psychoneurodermatologic Disorders. In: Norman, R.A. (eds) Diagnosis of Aging Skin Diseases. Springer, London. https://doi.org/10.1007/978-1-84628-678-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-84628-678-0_17
Publisher Name: Springer, London
Print ISBN: 978-1-84628-677-3
Online ISBN: 978-1-84628-678-0
eBook Packages: MedicineMedicine (R0)